<h3>關鍵洞察</h3>
<ul>
<li>東京應化工業的預計公允價值為 6,994 日元，基於兩階段自由現金流折現模型</li>
<li>東京應化工業的 4,969 日元股價表明其可能被低估 29%</li>
<li>分析師對 4186 的 4,863 日元目標價比我們估算的公允價值低 30%</li>
</ul>
<p>東京應化工業株式會社（TSE:4186）與其內在價值相差多遠？使用最新的財務數據，我們將通過估算公司的未來現金流並將其折現到現值，來看看該股票是否定價合理。實現這一目標的一種方法是採用折現現金流（DCF）模型。在你認為自己無法理解之前，請繼續閲讀！實際上，這比你想象的要簡單得多。</p>
<p>我們要提醒的是，評估公司的方法有很多種，像 DCF 一樣，每種技術在某些情況下都有其優缺點。如果你想了解更多關於折現現金流的信息，可以在 Simply Wall St 的分析模型中詳細閲讀這一計算的原理。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行研發。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<h2>估計估值是多少？</h2>
<p>我們將使用兩階段 DCF 模型，顧名思義，它考慮了兩個階段的增長。第一階段通常是一個較高的增長期，隨後趨於穩定，進入第二個 “穩定增長” 階段。首先，我們需要估算未來十年的現金流。在可能的情況下，我們使用分析師的估計，但當這些不可用時，我們會從最後的估計或報告值中推算出之前的自由現金流（FCF）。我們假設自由現金流減少的公司將減緩其減少的速度，而自由現金流增長的公司在此期間將看到其增長速度放緩。我們這樣做是為了反映出早期的增長往往比後期的增長放緩得更快。</p>
<p>通常我們假設今天的一美元比未來的一美元更有價值，因此我們需要將這些未來現金流的總和折現，以得出現值估計：</p>
<h4>10 年自由現金流（FCF）預測</h4>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td><strong>2026</strong></td>
<td><strong>2027</strong></td>
<td><strong>2028</strong></td>
<td><strong>2029</strong></td>
<td><strong>2030</strong></td>
<td><strong>2031</strong></td>
<td><strong>2032</strong></td>
<td><strong>2033</strong></td>
<td><strong>2034</strong></td>
<td><strong>2035</strong></td>
</tr>
<tr>
<td><strong>槓桿自由現金流（¥，百萬）</strong></td>
<td>166 億日元</td>
<td>179 億日元</td>
<td>254 億日元</td>
<td>314 億日元</td>
<td>358 億日元</td>
<td>393 億日元</td>
<td>421 億日元</td>
<td>442 億日元</td>
<td>459 億日元</td>
<td>471 億日元</td>
</tr>
<tr>
<td><strong>增長率估計來源</strong></td>
<td>分析師 x4</td>
<td>分析師 x5</td>
<td>分析師 x2</td>
<td>分析師 x1</td>
<td>估計 @13.90%</td>
<td>估計 @9.88%</td>
<td>估計 @7.07%</td>
<td>估計 @5.11%</td>
<td>估計 @3.73%</td>
<td>估計 @2.77%</td>
</tr>
<tr>
<td><strong>現值（¥，百萬）按 5.3% 折現</strong></td>
<td>158 億日元</td>
<td>161 億日元</td>
<td>217 億日元</td>
<td>255 億日元</td>
<td>276 億日元</td>
<td>288 億日元</td>
<td>293 億日元</td>
<td>292 億日元</td>
<td>288 億日元</td>
<td>281 億日元</td>
</tr>
</tbody>
</table>
<p><em>(&#34;Est&#34; = FCF 增長率由 Simply Wall St 估算)</em></p>
<p><strong>10 年現金流現值（PVCF）</strong> = 2,510 億日元</p>
<p>第二階段也稱為終值，這是企業在第一階段後的現金流。使用戈登增長公式計算終值，未來年增長率等於 10 年期政府債券收益率的 5 年平均值 0.5%。我們以 5.3% 的股本成本將終值現金流折現到今天的價值。</p>
<p><strong>終值（TV）</strong> = FCF2035 × (1 + g) ÷ (r – g) = 470 億日元× (1 + 0.5%) ÷ (5.3%– 0.5%) = 9,870 億日元</p>
<p><strong>終值現值（PVTV）</strong> = TV / (1 + r) 10= 9,870 億日元÷ ( 1 + 5.3%) 10= 5,880 億日元</p>
<p>總價值是未來十年的現金流總和加上折現後的終值，結果是總股本價值，在這種情況下為 8,380 億日元。要得到每股內在價值，我們將其除以總流通股數。相對於當前的 5,000 日元股價，該公司似乎略微被低估，折扣為 29%。不過，估值是一個不精確的工具，就像望遠鏡一樣——移動幾個度就會進入不同的星系。請記住這一點。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/880813-dcf-1-dark-2/1758752706704?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/880813-dcf-1-dark-2/1758752706704"/></p>
<p>TSE:4186 折現現金流 2025 年 9 月 24 日</p>
<h2>重要假設</h2>
<p>上述計算非常依賴於兩個假設。第一個是折現率，另一個是現金流。你不必同意這些輸入，我建議你自己重新計算並進行調整。DCF 模型也沒有考慮行業的週期性或公司的未來資本需求，因此並不能全面反映公司的潛在表現。鑑於我們將東京應化工業視為潛在股東，使用股本成本作為折現率，而不是資本成本（或加權平均資本成本，WACC），後者考慮了債務。在此計算中，我們使用了 5.3%，這是基於 0.915 的槓桿貝塔。貝塔是衡量股票相對於整體市場波動性的指標。我們從全球可比公司的行業平均貝塔中獲得我們的貝塔，並在 0.8 到 2.0 之間施加限制，這是一個適合穩定企業的合理範圍。</p>
<p>查看我們對東京應化工業的最新分析</p>
<h3>東京應化工業的 SWOT 分析</h3>
<p><strong>優勢</strong></p>
<ul>
<li>過去一年的盈利增長超過了行業水平。</li>
</ul>
<ul>
<li>債務不被視為風險。</li>
</ul>
<p>4186 的資產負債表摘要。</p>
<p><strong>劣勢</strong></p>
<ul>
<li>與化學市場前 25% 的分紅支付者相比，分紅較低。</li>
</ul>
<p><strong>機會</strong></p>
<ul>
<li>年收入預計將比日本市場增長更快。</li>
</ul>
<ul>
<li>交易價格低於我們估算的公允價值超過 20%。</li>
</ul>
<p><strong>威脅</strong></p>
<ul>
<li>分紅未被現金流覆蓋。</li>
</ul>
<ul>
<li>年度收益預計將比日本市場增長緩慢。</li>
</ul>
<p>查看 4186 的股息歷史。</p>
<h2>展望未來：</h2>
<p>雖然公司的估值很重要，但這只是評估公司時需要考慮的眾多因素之一。DCF 模型並不是一個完美的股票估值工具。相反，DCF 模型的最佳用途是測試某些假設和理論，以查看它們是否會導致公司被低估或高估。例如，公司的股本成本或無風險利率的變化可能會顯著影響估值。為什麼股價低於內在價值？對於東京應化工業，我們整理了三個您應該進一步審查的重要因素：</p>
<ol>
<li><strong>財務健康</strong>：4186 的資產負債表是否健康？查看我們免費的資產負債表分析，進行六項簡單檢查，關注槓桿和風險等關鍵因素。</li>
<li><strong>未來收益</strong>：4186 的增長率與其同行和更廣泛市場相比如何？通過與我們的免費分析師增長預期圖表互動，深入瞭解未來幾年的分析師共識數字。</li>
<li><strong>其他高質量替代品</strong>：您喜歡全能型股票嗎？探索我們互動式的高質量股票列表，瞭解您可能錯過的其他投資機會！</li>
</ol>
<p>PS. Simply Wall St 應用程序每天對東京證券交易所的每隻股票進行折現現金流估值。如果您想查找其他股票的計算，請在這裏搜索。</p>

<p>東京應化工業株式會社（TSE:4186）目前的交易價格為 4,969 日元，較其基於雙階段折現現金流（DCF）分析得出的估計公允價值 6,994 日元低 29%。分析師設定的目標價格為 4,863 日元，表明與公允價值估計相比，存在 30% 的低估。DCF 模型顯示總股本價值為 8,380 億日元，支持該股票被低估的觀點。然而，估值對摺現率和未來現金流的假設非常敏感</p>

<h3>Key Insights</h3>
<div class="lb-trans"><h3>關鍵洞察</h3>
</div><ul>
<li>The projected fair value for Tokyo Ohka Kogyo is JP¥6,994 based on 2 Stage Free Cash Flow to Equity</li>
<li>Tokyo Ohka Kogyo's JP¥4,969 share price signals that it might be 29% undervalued</li>
<li>The JP¥4,863 analyst price target for 4186 is 30% less than our estimate of fair value</li>
</ul>
<div class="lb-trans"><ul>
<li>東京應化工業的預計公允價值為 6,994 日元，基於兩階段自由現金流折現模型</li>
<li>東京應化工業的 4,969 日元股價表明其可能被低估 29%</li>
<li>分析師對 4186 的 4,863 日元目標價比我們估算的公允價值低 30%</li>
</ul>
</div><p>How far off is Tokyo Ohka Kogyo Co., Ltd. (TSE:4186) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine.</p>
<div class="lb-trans"><p>東京應化工業株式會社（TSE:4186）與其內在價值相差多遠？使用最新的財務數據，我們將通過估算公司的未來現金流並將其折現到現值，來看看該股票是否定價合理。實現這一目標的一種方法是採用折現現金流（DCF）模型。在你認為自己無法理解之前，請繼續閲讀！實際上，這比你想象的要簡單得多。</p>
</div><p>We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.</p>
<div class="lb-trans"><p>我們要提醒的是，評估公司的方法有很多種，像 DCF 一樣，每種技術在某些情況下都有其優缺點。如果你想了解更多關於折現現金流的信息，可以在 Simply Wall St 的分析模型中詳細閲讀這一計算的原理。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行研發。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><h2>What's The Estimated Valuation?</h2>
<div class="lb-trans"><h2>估計估值是多少？</h2>
</div><p>We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.</p>
<div class="lb-trans"><p>我們將使用兩階段 DCF 模型，顧名思義，它考慮了兩個階段的增長。第一階段通常是一個較高的增長期，隨後趨於穩定，進入第二個 “穩定增長” 階段。首先，我們需要估算未來十年的現金流。在可能的情況下，我們使用分析師的估計，但當這些不可用時，我們會從最後的估計或報告值中推算出之前的自由現金流（FCF）。我們假設自由現金流減少的公司將減緩其減少的速度，而自由現金流增長的公司在此期間將看到其增長速度放緩。我們這樣做是為了反映出早期的增長往往比後期的增長放緩得更快。</p>
</div><p>Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:</p>
<div class="lb-trans"><p>通常我們假設今天的一美元比未來的一美元更有價值，因此我們需要將這些未來現金流的總和折現，以得出現值估計：</p>
</div><h4>10-year free cash flow (FCF) forecast</h4>
<div class="lb-trans"><h4>10 年自由現金流（FCF）預測</h4>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td><strong>2026</strong></td>
<td><strong>2027</strong></td>
<td><strong>2028</strong></td>
<td><strong>2029</strong></td>
<td><strong>2030</strong></td>
<td><strong>2031</strong></td>
<td><strong>2032</strong></td>
<td><strong>2033</strong></td>
<td><strong>2034</strong></td>
<td><strong>2035</strong></td>
</tr>
<tr>
<td><strong>Levered FCF (¥, Millions)</strong></td>
<td>JP¥16.6b</td>
<td>JP¥17.9b</td>
<td>JP¥25.4b</td>
<td>JP¥31.4b</td>
<td>JP¥35.8b</td>
<td>JP¥39.3b</td>
<td>JP¥42.1b</td>
<td>JP¥44.2b</td>
<td>JP¥45.9b</td>
<td>JP¥47.1b</td>
</tr>
<tr>
<td><strong>Growth Rate Estimate Source</strong></td>
<td>Analyst x4</td>
<td>Analyst x5</td>
<td>Analyst x2</td>
<td>Analyst x1</td>
<td>Est @ 13.90%</td>
<td>Est @ 9.88%</td>
<td>Est @ 7.07%</td>
<td>Est @ 5.11%</td>
<td>Est @ 3.73%</td>
<td>Est @ 2.77%</td>
</tr>
<tr>
<td><strong>Present Value (¥, Millions) Discounted @ 5.3%</strong></td>
<td>JP¥15.8k</td>
<td>JP¥16.1k</td>
<td>JP¥21.7k</td>
<td>JP¥25.5k</td>
<td>JP¥27.6k</td>
<td>JP¥28.8k</td>
<td>JP¥29.3k</td>
<td>JP¥29.2k</td>
<td>JP¥28.8k</td>
<td>JP¥28.1k</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td><strong>2026</strong></td>
<td><strong>2027</strong></td>
<td><strong>2028</strong></td>
<td><strong>2029</strong></td>
<td><strong>2030</strong></td>
<td><strong>2031</strong></td>
<td><strong>2032</strong></td>
<td><strong>2033</strong></td>
<td><strong>2034</strong></td>
<td><strong>2035</strong></td>
</tr>
<tr>
<td><strong>槓桿自由現金流（¥，百萬）</strong></td>
<td>166 億日元</td>
<td>179 億日元</td>
<td>254 億日元</td>
<td>314 億日元</td>
<td>358 億日元</td>
<td>393 億日元</td>
<td>421 億日元</td>
<td>442 億日元</td>
<td>459 億日元</td>
<td>471 億日元</td>
</tr>
<tr>
<td><strong>增長率估計來源</strong></td>
<td>分析師 x4</td>
<td>分析師 x5</td>
<td>分析師 x2</td>
<td>分析師 x1</td>
<td>估計 @13.90%</td>
<td>估計 @9.88%</td>
<td>估計 @7.07%</td>
<td>估計 @5.11%</td>
<td>估計 @3.73%</td>
<td>估計 @2.77%</td>
</tr>
<tr>
<td><strong>現值（¥，百萬）按 5.3% 折現</strong></td>
<td>158 億日元</td>
<td>161 億日元</td>
<td>217 億日元</td>
<td>255 億日元</td>
<td>276 億日元</td>
<td>288 億日元</td>
<td>293 億日元</td>
<td>292 億日元</td>
<td>288 億日元</td>
<td>281 億日元</td>
</tr>
</tbody>
</table>
</div><p><em>(&#34;Est&#34; = FCF growth rate estimated by Simply Wall St)</em></p>
<div class="lb-trans"><p><em>(&#34;Est&#34; = FCF 增長率由 Simply Wall St 估算)</em></p>
</div><p><strong>Present Value of 10-year Cash Flow (PVCF)</strong> = JP¥251b</p>
<div class="lb-trans"><p><strong>10 年現金流現值（PVCF）</strong> = 2,510 億日元</p>
</div><p>The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.5%. We discount the terminal cash flows to today's value at a cost of equity of 5.3%.</p>
<div class="lb-trans"><p>第二階段也稱為終值，這是企業在第一階段後的現金流。使用戈登增長公式計算終值，未來年增長率等於 10 年期政府債券收益率的 5 年平均值 0.5%。我們以 5.3% 的股本成本將終值現金流折現到今天的價值。</p>
</div><p><strong>Terminal Value (TV)</strong> = FCF2035 × (1 + g) ÷ (r – g) = JP¥47b× (1 + 0.5%) ÷ (5.3%– 0.5%) = JP¥987b</p>
<div class="lb-trans"><p><strong>終值（TV）</strong> = FCF2035 × (1 + g) ÷ (r – g) = 470 億日元× (1 + 0.5%) ÷ (5.3%– 0.5%) = 9,870 億日元</p>
</div><p><strong>Present Value of Terminal Value (PVTV)</strong> = TV / (1 + r) 10= JP¥987b÷ ( 1 + 5.3%) 10= JP¥588b</p>
<div class="lb-trans"><p><strong>終值現值（PVTV）</strong> = TV / (1 + r) 10= 9,870 億日元÷ ( 1 + 5.3%) 10= 5,880 億日元</p>
</div><p>The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is JP¥838b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of JP¥5.0k, the company appears a touch undervalued at a 29% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.</p>
<div class="lb-trans"><p>總價值是未來十年的現金流總和加上折現後的終值，結果是總股本價值，在這種情況下為 8,380 億日元。要得到每股內在價值，我們將其除以總流通股數。相對於當前的 5,000 日元股價，該公司似乎略微被低估，折扣為 29%。不過，估值是一個不精確的工具，就像望遠鏡一樣——移動幾個度就會進入不同的星系。請記住這一點。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/880813-dcf-1-dark-2/1758752706704" alt="" original-src="https://images.simplywall.st/asset/chart/880813-dcf-1-dark-2/1758752706704"/></p>
<p>TSE:4186 Discounted Cash Flow September 24th 2025</p>
<div class="lb-trans"><p>TSE:4186 折現現金流 2025 年 9 月 24 日</p>
</div><h2>Important Assumptions</h2>
<div class="lb-trans"><h2>重要假設</h2>
</div><p>The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Tokyo Ohka Kogyo as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.3%, which is based on a levered beta of 0.915. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.</p>
<div class="lb-trans"><p>上述計算非常依賴於兩個假設。第一個是折現率，另一個是現金流。你不必同意這些輸入，我建議你自己重新計算並進行調整。DCF 模型也沒有考慮行業的週期性或公司的未來資本需求，因此並不能全面反映公司的潛在表現。鑑於我們將東京應化工業視為潛在股東，使用股本成本作為折現率，而不是資本成本（或加權平均資本成本，WACC），後者考慮了債務。在此計算中，我們使用了 5.3%，這是基於 0.915 的槓桿貝塔。貝塔是衡量股票相對於整體市場波動性的指標。我們從全球可比公司的行業平均貝塔中獲得我們的貝塔，並在 0.8 到 2.0 之間施加限制，這是一個適合穩定企業的合理範圍。</p>
</div><p>Check out our latest analysis for Tokyo Ohka Kogyo</p>
<div class="lb-trans"><p>查看我們對東京應化工業的最新分析</p>
</div><h3>SWOT Analysis for Tokyo Ohka Kogyo</h3>
<div class="lb-trans"><h3>東京應化工業的 SWOT 分析</h3>
</div><p><strong>Strength</strong></p>
<div class="lb-trans"><p><strong>優勢</strong></p>
</div><ul>
<li>Earnings growth over the past year exceeded the industry.</li>
</ul>
<div class="lb-trans"><ul>
<li>過去一年的盈利增長超過了行業水平。</li>
</ul>
</div><ul>
<li>Debt is not viewed as a risk.</li>
</ul>
<div class="lb-trans"><ul>
<li>債務不被視為風險。</li>
</ul>
</div><p>Balance sheet summary for 4186.</p>
<div class="lb-trans"><p>4186 的資產負債表摘要。</p>
</div><p><strong>Weakness</strong></p>
<div class="lb-trans"><p><strong>劣勢</strong></p>
</div><ul>
<li>Dividend is low compared to the top 25% of dividend payers in the Chemicals market.</li>
</ul>
<div class="lb-trans"><ul>
<li>與化學市場前 25% 的分紅支付者相比，分紅較低。</li>
</ul>
</div><p><strong>Opportunity</strong></p>
<div class="lb-trans"><p><strong>機會</strong></p>
</div><ul>
<li>Annual revenue is forecast to grow faster than the Japanese market.</li>
</ul>
<div class="lb-trans"><ul>
<li>年收入預計將比日本市場增長更快。</li>
</ul>
</div><ul>
<li>Trading below our estimate of fair value by more than 20%.</li>
</ul>
<div class="lb-trans"><ul>
<li>交易價格低於我們估算的公允價值超過 20%。</li>
</ul>
</div><p><strong>Threat</strong></p>
<div class="lb-trans"><p><strong>威脅</strong></p>
</div><ul>
<li>Dividends are not covered by cash flow.</li>
</ul>
<div class="lb-trans"><ul>
<li>分紅未被現金流覆蓋。</li>
</ul>
</div><ul>
<li>Annual earnings are forecast to grow slower than the Japanese market.</li>
</ul>
<div class="lb-trans"><ul>
<li>年度收益預計將比日本市場增長緩慢。</li>
</ul>
</div><p>See 4186's dividend history.</p>
<div class="lb-trans"><p>查看 4186 的股息歷史。</p>
</div><h2>Looking Ahead:</h2>
<div class="lb-trans"><h2>展望未來：</h2>
</div><p>Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. The DCF model is not a perfect stock valuation tool. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. What is the reason for the share price sitting below the intrinsic value? For Tokyo Ohka Kogyo, we've put together three important elements you should further examine:</p>
<div class="lb-trans"><p>雖然公司的估值很重要，但這只是評估公司時需要考慮的眾多因素之一。DCF 模型並不是一個完美的股票估值工具。相反，DCF 模型的最佳用途是測試某些假設和理論，以查看它們是否會導致公司被低估或高估。例如，公司的股本成本或無風險利率的變化可能會顯著影響估值。為什麼股價低於內在價值？對於東京應化工業，我們整理了三個您應該進一步審查的重要因素：</p>
</div><ol>
<li><strong>Financial Health</strong>: Does 4186 have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.</li>
<li><strong>Future Earnings</strong>: How does 4186's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.</li>
<li><strong>Other High Quality Alternatives</strong>: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!</li>
</ol>
<div class="lb-trans"><ol>
<li><strong>財務健康</strong>：4186 的資產負債表是否健康？查看我們免費的資產負債表分析，進行六項簡單檢查，關注槓桿和風險等關鍵因素。</li>
<li><strong>未來收益</strong>：4186 的增長率與其同行和更廣泛市場相比如何？通過與我們的免費分析師增長預期圖表互動，深入瞭解未來幾年的分析師共識數字。</li>
<li><strong>其他高質量替代品</strong>：您喜歡全能型股票嗎？探索我們互動式的高質量股票列表，瞭解您可能錯過的其他投資機會！</li>
</ol>
</div><p>PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the TSE every day. If you want to find the calculation for other stocks just search here.</p>
<div class="lb-trans"><p>PS. Simply Wall St 應用程序每天對東京證券交易所的每隻股票進行折現現金流估值。如果您想查找其他股票的計算，請在這裏搜索。</p>
</div>

東京應化工業株式會社（TSE:4186）的交易價格是否低於其價值 29%？